REFERENCES
- Chang T MS. Editorial: Is there a need for blood substitutes in the new millennium and what can we expect in way of safety and efficacy?. Art Cells Blood Sub Immob Biotech 2000; 28: i–vii
- Alayash A I. Editorial: Is there a need for blood substitutes in the new millennium and what can we expect in way of safety and efficacy?. From a research perspective. Artif. Cells, Blood Sub. Immob. Biotech 2000; 29(1)
- Hsia J C. Pasteurizable, freeze-driable hemoglobin-based blood substitute. US Patent No. 4,857,626, 1989
- Hsia J C. Compositions and methods using nitroxides to avoid oxygen toxicity, particularly in stabilized, polymerized, conjugated or encapsulated hemoglobin used as a red cell substitute. US Patent No. 5,591,710, 1997
- D'Agnillo F, Chang T M. Polyhemoglobin-superoxide dismutase-catalase as a blood substitute with antioxidant properties. Nat Biotechnol 1998; 16(7)667–71
- Okayama N, Park J H, Coe L, Granger D N, Ma L, Hsia C J, Alexander J S. Polynitroxyl αα-hemoglobin (PNH) inhibits peroxide and superoxide-mediated neutrophil adherence to human endothelial cells. Free Radic Res 1999; 31(1)53–8
- McLeod L L, Alayash A I. Detection of a ferrylhemoglobin intermediate in an endothelial cell model after hypoxia-reoxygenation. Am J Physiol 1999; 277(1 Pt 2)92–9
- Krishna M C, Samuni A, Taira J, Goldstein S, Mitchell J B, Russo A. Stimulation by nitroxides of catalase-like activity of hemeproteins. Kinetics and mechanism. J Biol Chem 1996; 271(42)26018–25
- Krishna M C, Ma L, Samuni A, Trimble C E, Mitchell J B, Hsia C JC. Superoxide Dismutase- and Catalase-Mimetic Activity of a Polynitroxyl Hemoglobin (PNH). Artif. Cells, Blood Sub. Immob. Biotech 1996; 24: 369
- Faivre-Fiorina B, Caron A, Labrude P, Vigneron C. Erythrocyte, plasma and substitute hemoglobins facing physiological oxidizing and reducing agents. Ann Biol Clin (Paris) 1998; 56(5)545–56
- Samuni A, Karmeli F, Moshen M, Rachmilewitz D. Mechanisms underlying gastric anti-ulcerative activity of nitroxides in rats. Free Rad Res 1999; 30(2)133–40
- Kentner R, Ma L, Behringer W, Safer P, Hsia C JC, Tisherman S. Antioxidant polynitroxylated albumin (PNA) plus tempol for hemorrhagic shock(HS) in rats: improved survival with early treatment (submitted for publication)
- Saetzler R K, Arfors K E, Tuma R F, Vasthare U, Ma L, Hsia C J, Lehr H A. Polynitroxylated hemoglobin-based oxygen carrier: inhibition of free radical-induced microcirculatory dysfunction. Free Radic Biol Med. 1999; 27(1–2)1–6
- Patel P M, Harada H, Ma L, Trimble C E, Hsia C JC. Polynitroxyl hemoglobin (PNH) reduces cerebral infraction following transient cerebral artery occlusion in the HRS rat. Shock 1998; 9: 61
- Eich R F, Li T, Lemon D D, Doherty D H, Curry S R, Aitken J F, Mathews A J, Johnson K A, Smith R D, Phillips G N, Jr., Olson J S. Mechanism of NO-induced oxidation of myoglobin and hemoglobin. Biochemistry 1996; 35(22)6976–83
- Haney C R, Buehler P W, Gulati A. Purification and chemical modifications of hemoglobin in developing hemoglobin based oxygen carriers. Adv Drug Deliv Rev 28 2000; 40(3)153–69
- Jia L, Bonaventura C, Bonaventura J, Stamler J S. s-Nitrosohaemoglobin: a dynamic activity of blood involved control. Nature 1999; 380(6571)221–6
- Buehler P, Ma L, Trimble C E, Hsia C JC, Gulati A. Dextran conjugation of polynitroxylated -crosslinked hemodynamics and outcome of hemorrhaged rats. Shock 2000; 13: 56
- Winslow R M. Blood substitutes: refocusing an elusive goal. British J Heamatology 2000; 111: 1–11
- Tam S C, Blumenstein J, Wong J T. Blood replacement in dogs by dextran-hemoglobin. Can J Biochem 1978; 56(10)981–4